Search Within
Document Type
237-272-7
Applied Filters:
Keyword:'237-272-7'
Showing 1-30 of 34 results for "237-272-7" within Technical Documents
Caspase 8 human (C1099)
Biochem. Sci., 22(8), 299-306 (1997).
7. Scaffidi, C., et al., J. Biol. Chem., 272(43), 26953-
26958 (1997).
8. Hu, S., et al., J. Biol. Chem., 272(28), 17255-17257
(1997).
9. Martin, D.A
MMP Activation Chart
Collagenase
72
aa=71.0
active-MMP-7 37oC, 8h C ? n.d. 0.6x
Stetler-Stevenson et al., jbc 1989,
264, 1353; Nagase et al., Matrix
Suppl. 1992 1:237 Crabbe FEBS
RABBIT ANTI-CXCR4 (EXTRACELLULAR LOOP)
Nature. 382:829-833.
7. Oberlin, E et al. (1996) Nature. 382:833-835.
8. Lapham, CK et al. (1996) Science. 274:602-605.
9. Leotscher, M et al. (1994) J Biol Chem. 269:232-237.
10. Brelot, A et al.
Data Sheet - C8352
transmembrane domain receptor, LESTR, that is
highly expressed in leukocytes. J. Biol. Chem., 269,
232-237 (1994).
3. Wells, T.N., et al., Definition, function and
pathophysiological significance of chemokine
Data Sheet - C8227
transmembrane domain receptor, LESTR, that is
highly expressed in leukocytes. J. Biol. Chem., 269,
232-237 (1994).
3. Wells, T.N., et al., Definition, function and
pathophysiological significance of chemokine
CAPASE 6 HUMAN RECOMBINANT C-terminal histidine tagged protein Expressed in E. coli
pentapeptide of general
structure QACXG (where X is R, Q or G). The amino
acids Cys-285 and His-237 involved in catalysis, and
those involved in forming the P1 carboxylate binding
pocket (Arg-179
Data Sheet - A0303
Ishibashi, K., et al., Am. J. Physiol., 272, F235
(1997).
6. Preston, B.M., et al., Science 256, 385 (1992).
7. Ishibashi, K., et al., Biochem. Biophys. Res.
Commun. 237, 714 (1997).
8. Park, J.H. and Saier
Data Sheet - A7310
Fushimi, K. et al., J. Biol. Chem., 272, 14800
(1997).
6. Preston, B.M., et al., Science 256, 385 (1992).
7. Ishibashi, K., et al., Biochem. Biophys. Res.
Commun. 237, 714 (1997).
8. Park, J.H. and
XP725 Antibody Number-Lot Number 071M4826
278 279 280
3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284
3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288
4.1 289 290 291 292 313
LABORATORY NOTEBOOK ISSUANCE PAGE
Neodymium Nd 60 144.242(3)
Neon Ne 10 20.1797(6)
Neptunium Np 93 [237]
Nickel Ni 28 58.6934(4)
Niobium Nb 41 92.906 38(2)
Nitrogen N 7 [14.006 43; 14.007 28]
Nobelium No 102 [259]
Osmium Os 76 190.23(3
LABORATORY NOTEBOOK ISSUANCE PAGE
Neodymium Nd 60 144.242(3)
Neon Ne 10 20.1797(6)
Neptunium Np 93 [237]
Nickel Ni 28 58.6934(4)
Niobium Nb 41 92.906 38(2)
Nitrogen N 7 [14.006 43; 14.007 28]
Nobelium No 102 [259]
Osmium Os 76 190.23(3
LABORATORY NOTEBOOK ISSUANCE PAGE
Neodymium Nd 60 144.242(3)
Neon Ne 10 20.1797(6)
Neptunium Np 93 [237]
Nickel Ni 28 58.6934(4)
Niobium Nb 41 92.906 38(2)
Nitrogen N 7 [14.006 43; 14.007 28]
Nobelium No 102 [259]
Osmium Os 76 190.23(3
FlowCellect™ Chemokine Receptor CCR2b Surface Expression Identification kit
Evidence for the role of the carboxyl-terminal tail in
receptor trafficking. J. Biol. Chem. 272: 1038-45.
7. Schertler GFX (1992). Overproduction of membrane proteins. Curr Opin Struct Biol. 2: 534-
Application Notes Pharmaceutical impurity profiling Application guide
equipped with a 237 nm detector
Amlodipine Besylate and Related Substances
From Particulate to Monolithic Column
(test 1) and HPLC (test 2) where the liquid chromatograph is equipped with a 237 nm detector
Calbiochem Biologics 29.4
et al. 2002. Cancer Chemother. Pharmacol. 50, 479; Svingen, P.A., et al. 2000. Clin. Cancer Res. 6, 237.
AG 592 (AGL 2592)
A selective, cell-permeable inhibitor of tyrosine kinase activity of EGFR (IC50
Chrombook 2015 - The world of chromatography in your hands
326
1.50582.0001 326
1.50583.0001 326
1.50593.0001 272
1.50595.0001 272
1.50596.0001 272
1.50597.0001 272
1.50598.0001 272
1.50600.0001 316
1.50600.1003 316
Ordering No. Page
Calbiochem Biologics 30.2
$ 315
Cat. No. CBA011 1 kit $ 152
Cat. No. CBA013 1 kit $ 184
Cat. No. CBA012 1 kit $ 237
CORRECTIONS 11.10.04.indd Sec2:13CORRECTIONS 11.10.04.indd Sec2:13 11/10/04
Research Article: MCP-1, KC-like and IL-8 as critical mediators of
Uncomplicated day 7 (n = 13)
Min-Max 139–272 117–2009 12–276 39–183 1391–6294 1–1 29–1109 2–762 156–282
Median 154 440 28 68 2852 1 184 145 191
SD 44 474 87 48 1362 0 309 231 42
XP725 Antibody List Lot 129K4831
n/d n/d
272 FBI-1/PAKEMON F9429 51341 ZBTB7A P NP_056982.1 y n/d n/d
155 Cdh1 C7855 51343 FZR1 M NP_001129669.1 y n/d n/d
333 HDAC-7 H2537 51564 HDAC7 P NP_001091886.1 y y y
334 HDAC-7 H6663 51564
XP725 Antibody List Lot 129K4830
n/d n/d
272 FBI-1/PAKEMON F9429 51341 ZBTB7A P NP_056982.1 y n/d n/d
155 Cdh1 C7855 51343 FZR1 M NP_001129669.1 y n/d n/d
333 HDAC-7 H2537 51564 HDAC7 P NP_001091886.1 y y y
334 HDAC-7 H6663 51564
Top Trends in Single-use Biomanufacturing
205 338
6 9 Amgen 204 225
7 4 Biogen 196 316
8 - Pfizer 149 -
9 - Celltrion 140 -
10 - Lilly 137 -
- 2 Samsung - 362
-
XP725 Antibody List Lot 089K4791
n/d n/d
272 FBI-1/PAKEMON F9429 51341 ZBTB7A P NP_056982.1 y n/d n/d
155 Cdh1 C7855 51343 FZR1 M NP_001129669.1 y n/d n/d
333 HDAC-7 H2537 51564 HDAC7 P NP_001091886.1 y y y
334 HDAC-7 H6663 51564
List of Antibodies
DR4 D3813 P y n/d n/d
234 DR5 D3938 P y n/d n/d
235 DR6 D1564 P y n/d n/d
236 DRAK1 D1314 P y y y
237 Dystrophin D8168 M y y y
238 Dystrophin D8043 M y y y
239 E2F1 E9026 P y
XP725 Worksheet for Lot Number 071M4826
231 2 1 5 7 Caspase 4 C3392
232 2 1 5 8 Caspase 4 C3392
233 2 1 6 1 Caspase 5 C6979
234 2 1 6 2 Caspase 5 C6979
235 2 1 6 3 Caspase 6 C7599
236 2 1 6 4
Perfection in every dimension 2014. Inorganic reagents Catalogue
loading may not exceed
5.2 g H2O / 100 g silica gel.
272
273
Silica gel [SiO2] – continued
Indicator change
in orange gel
At approx. 7 – 10 g
Protein Purification and Detection Tools
Cat. No. Price
BugBuster® Protein
Extraction Reagent
100 ml
500 ml
70584-3
70584-4
$58
$237
BugBuster® Master Mix
Extraction Reagent
100 ml
500 ml
71456-3
71456-4
$147
$457
BugBuster
XP725 Antibody List
235 DR6 D1564 27242 TNFRSF21 NP_055267.1 P y n/d n/d
236 DRAK1 D1314 9263 STK17A NP_004751.2 P y y y
237 Dystrophin D8168 24907, 1756, 13405 DMD,Dmd NP_036830.2,NP_004014.1,NP_031894.1 M y y y
238 Dystrophin
3D BIOPRINTING: Printing a Brighter Future
Physiol. Heart Circ. 1997, 272 (6), H2716–H2725.
(6) Dhinakaran, V.; Kumar, K.; Ram, P.; Ravichandran, M.; Vinayagamoorthy,
M. Mater. Today: Proc. 2020, 27, 752–756.
(7) Melchels, F.; Feijen, J.; Grijpma
3D BIOPRINTING: Printing a Brighter Future
Physiol. Heart Circ. 1997, 272 (6), H2716–H2725.
(6) Dhinakaran, V.; Kumar, K.; Ram, P.; Ravichandran, M.; Vinayagamoorthy,
M. Mater. Today: Proc. 2020, 27, 752–756.
(7) Melchels, F.; Feijen, J.; Grijpma
XP725 Antibody List 013M4793
235 DR6 D1564 27242 TNFRSF21 NP_055267.1 P y n/d n/d
236 DRAK1 D1314 9263 STK17A NP_004751.2 P y y y
237 Dystrophin D8168 24907, 1756, 13405 DMD,Dmd NP_036830.2,NP_004014.1,NP_031894.1 M y y y
238 Dystrophin
Page 1 of 2